Vanguard Health Care Fund Investor Shares (VGHCX)
| Fund Assets | 36.96B |
| Expense Ratio | 0.33% |
| Min. Investment | $3,000 |
| Turnover | 47.00% |
| Dividend (ttm) | 12.98 |
| Dividend Yield | 6.20% |
| Dividend Growth | -38.58% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Mar 30, 2026 |
| Previous Close | 212.46 |
| YTD Return | 8.16% |
| 1-Year Return | 31.86% |
| 5-Year Return | 45.94% |
| 52-Week Low | 167.00 |
| 52-Week High | 212.65 |
| Beta (5Y) | 0.54 |
| Holdings | 103 |
| Inception Date | May 23, 1984 |
About VGHCX
For over a quarter-century, this actively managed fund has provided investors with an economical way to access a diverse range of companies operating within the global healthcare industry. Its holdings span various segments, including pharmaceutical developers, medical equipment manufacturers, and groundbreaking research institutions. Compared to other healthcare-focused funds, it generally boasts broader international exposure and tends to have a more stable portfolio with less frequent trading. However, a key consideration for investors is its specialized concentration, as all investments are exclusively confined to the healthcare sector. Given that yearly performance can fluctuate considerably, this fund is best suited as a supplementary component within a broader, well-rounded investment portfolio, especially for those with a long-term outlook.
Performance
VGHCX had a total return of 31.86% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.61%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| VGHAX | Admiral Shares | 0.27% |
Top 10 Holdings
40.71% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.08% |
| Merck & Co., Inc. | MRK | 5.41% |
| AstraZeneca PLC | AZN | 5.09% |
| UnitedHealth Group Incorporated | UNH | 3.92% |
| Johnson & Johnson | JNJ | 3.45% |
| Edwards Lifesciences Corporation | EW | 3.21% |
| GSK plc | GSK | 3.13% |
| Intuitive Surgical, Inc. | ISRG | 2.71% |
| Boston Scientific Corporation | BSX | 2.36% |
| Danaher Corporation | DHR | 2.35% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 30, 2026 | $7.65777 | Mar 31, 2026 |
| Dec 19, 2025 | $5.3174 | Dec 22, 2025 |
| Mar 28, 2025 | $3.48195 | Mar 31, 2025 |
| Dec 20, 2024 | $17.64181 | Dec 23, 2024 |
| Mar 27, 2024 | $6.15768 | Mar 28, 2024 |
| Dec 27, 2023 | $8.25288 | Dec 28, 2023 |